Conference Description:

Discover the latest advancements in biomarkers at the 8th Annual Biomarker & Precision Medicine US Congress. Join experts from global pharma, top biotechs, and renowned academic institutions to explore emerging tools and strategies in translational science, diagnostics, and biomarker development.

Built with industry experts in mind, the conference program highlights:
• Exciting biomarker technologies impacting R&D in 2024
• Multi-omics, spatial biology, digital markers, and next-gen diagnostics
• The opportunity to engage with regulators, diagnostics manufacturers, and biopharma peers

Meet our Key Speakers:
• Kristina McGuire, Executive Director & Head, CDx & Laboratory Operations, Regeneron
• Robert Getzenberg, Medical Director Diagnostics, Oncology, Astellas
• Satya Saxenda, Director, Global Proteomics, Clinical Pharmacology & Translational Medicine, Eisai
• Lokesh Agrawal, Program Director, National Cancer Institute
• Heather Cohen, Senior Director, Translational Sciences, Bicycle Therapeutics
• Nandini Rudraganguly, Associate Director, Precision Medicine Oncology, AbbVie
• Anand Giddabasappa, Head of Global Science & Technology, Pfizer
• Jean-Francois Martin, Executive Director – Diagnostics & Translational Oncology, Pfizer